08223 ZYY
- 1.730
- +0.010+0.58%
ZYY News
Ziyuanyuan Holdings Group Limited (HKG:8223) Insiders Have Had a Fantastic Week as Stock Increased 66%, and They Haven't Stopped Buying
Key Insights Ziyuanyuan Holdings Group's significant insider ownership suggests inherent interests in company's expansion Junshen Zhang owns 51% of the company Insiders have bought recently To
Zyy (08223.HK): Tian Zhiwei replaces Huang Guoxin as the company's executive director.
On June 19th, Gelunhui announced that Huang Guoxin has resigned from the position of company executive director in order to devote more time to other business activities under his responsibility, effective on June 19, 2024. But Huang Guoxin will continue to serve the group as an authorized representative, joint financial director, joint company secretary, and director of several subsidiaries in Hong Kong. At the same time, Tian Zhiwei was appointed as the company's executive director and member of the remuneration committee, effective from June 19, 2024.
Express News | Ziyuanyuan Holdings - Tian Zhiwei Appointed as Executive Director
Express News | Ziyuanyuan Holdings - Wong Kwok San Stepped Down as Executive Director
Ziyuanyuan Holdings Group Limited's (HKG:8223) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
To the annoyance of some shareholders, Ziyuanyuan Holdings Group Limited (HKG:8223) shares are down a considerable 25% in the last month, which continues a horrid run for the company. The drop over
ZYY: 2023 ANNUAL REPORT
Ziyuan Announces 2023 Annual Results Profit attributable to shareholders of 145.63 million yuan, a year-on-year decrease of 7.9%
Ziyuanyuan (08223) announced the results for the year ended December 31, 2023. The group obtained total revenue of RMB 498 million (same unit), an increase of 53.41% year on year; profit attributable to company owners was RMB 145.63 million, a decrease of 7.9% year on year; profit per share was 3.64 points.
Ziyuan Yuan (08223) announced annual results. Profit attributable to shareholders of 145.63 million yuan decreased by 7.9% year-on-year
Ziyuanyuan (08223) announced the results for the year ended December 31, 2023. The group obtained total revenue, people...
ZYY: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2023
Ziyuanyuan Holdings Group Limited's (HKG:8223) 28% Share Price Plunge Could Signal Some Risk
The Ziyuanyuan Holdings Group Limited (HKG:8223) share price has softened a substantial 28% over the previous 30 days, handing back much of the gains the stock has made lately. Longer-term, the sto
What Ziyuanyuan Holdings Group Limited's (HKG:8223) 26% Share Price Gain Is Not Telling You
Ziyuanyuan Holdings Group Limited (HKG:8223) shareholders would be excited to see that the share price has had a great month, posting a 26% gain and recovering from prior weakness. The bad news is
Ziyuanyuan (08223) plans to discount approximately 19.23% and issue 30 million subscription shares to raise about HK$43.5 million net
According to the Zhitong Finance App, Ziyuan (08223) announced that on December 29, 2023, the company plans to issue 15 million subscription shares to Yu Jianping and Zheng Zhihong respectively. The subscription price for each subscribed share is HK$1.47, a discount of about 19.23% from the closing price of HK$1.82 per share. Net funding of approximately HK$43.5 million is intended to be used for general working capital to develop the Group's financial leasing business and medical device and consumables trading business. On the same day, that is, the final end date of the placement agreement, the prerequisites for the placement agreement have not been met, and the proposed transactions under the placement agreement have expired and been terminated
Zi Yuanyuan (08223) discounted about 13%, net value of about HK$42.7 million, did not fall but rose nearly 30%
Jinwu Financial News | Ziyuan Yuan (08223) rose nearly 30% to HK$1.62. The stock closed down 13% on the previous trading day. According to the news, Zi Yuanyuan announced that it will place up to 40 million shares, accounting for about 9.09% of the expanded share capital. The placement price is HK$1.11 per share, a discount of about 13.28% from the closing price of HK$1.28 on the 12th. The total proceeds amount is about HK$44.4 million, a net amount of about HK$42.7 million, of which about 20-30% will cover ongoing administrative and operating expenses, and 70-80% will be used to develop the Group's financial leasing business and medical device and consumables trading business.
Zi Yuanyuan (08223) plans to discount approximately 13.28%, place up to 40 million shares, place up to 40 million shares, net raise about HK$42.7 million
Zi Yuanyuan (08223) issued an announcement. On December 12, 2023, the company signed a placement agreement with the placement agent...
Zi Yuanyuan (08223.HK) plans to further develop medical device and consumables trading business
Gelonghui November 24 | Zi Yuanyuan (08223.HK) announced that on November 24, 2023, the company (“buyer”) signed a memorandum of understanding with He Chao, Shenzhen Yunrui Investment Limited Partnership (Limited Partnership) and Shenzhen Borui Cloud Investment Partnership (“Seller”). According to the MOU, the buyer intended to buy and the seller intended to sell shares of Shenzhen Chuangda Yunrui Intelligent Technology Co., Ltd. (“Target Company”) and the buyer intended to inject capital into the target company. After the shares to be sold and capital injections are completed, the Group intends to own 51% of the target company's shares. The target company is a limited company established in China
ZYY: THIRD QUARTERLY REPORT 2023
ZYY: THIRD QUARTERLY RESULTS ANNOUNCEMENTFOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023
Zi Yuanyuan (08223.HK) plans to buy Guangdong Dejiang Medical Products Co., Ltd. to develop medical device and consumables trading business
Gelonghui, October 27, Ziyuanyuan (08223.HK) announced that on October 27, 2023, the Company (“Buyer”) signed a Memorandum of Understanding with Hu Yang and Shenzhen Dejiang Investment Co., Ltd. (“Seller”). According to the MOU, the buyer intended to buy and the seller intended to sell shares in Guangdong Dejiang Medical Products Co., Ltd. (“Target Company”). The target company is a limited company established in China, founded in 2017, dedicated to R&D, manufacturing and sales of medical physiotherapy equipment. The founding team of the target company comes from well-known companies in the industry and has many years of work experience in the medical device industry
ZYY: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2022
ZYY: INTERIM REPORT 2023
Analysis
Price Target
No Data
